Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-02 13:53:37 - browse：4

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb will pay $4.1 billion for RayzeBio, the companies said Tuesday, buying into the fast-growing field of using targeted doses of radiation to treat cancer.

RayzeBio, which raised about $350 million in a September initial public offering, is working in radiopharmaceuticals, which pair the tumor-killing power of radiation with the precision of targeted cancer therapies. The company is currently running a pivotal trial of its most advanced drug, RYZ101, in neuroendocrine cancer and has a pipeline of treatments for kidney, liver, and other cancers.

Bristol Myers will pay $62.50 in cash per share of RayzeBio, a roughly 115% premium to the company’s recent trading and more than triple the company’s IPO price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： White House drug shortages task force keeps mum with Congress

leisure time

WSS

New brain studies show LSD's effects on the brain in full color

My yearlong odyssey to get my son’s ADHD medication covered

Independent physicians launch a new lobbying group

New brain studies show LSD's effects on the brain in full color

Large hospital system sues Multiplan for low

CDC overhauls leadership of center that led response to Covid

Wikipedia

Wikipedia

explore

Alkermes shareholders re

Copay coupons to count toward deductibles, after Biden court move

Supreme Court strikes down use of affirmative action

Dewpoint Therapeutics lays off staff after losing partnerships

Moonlake's readout produced a cash windfall. Risks remain

AI generated plenty of interest at JPM but not a lot of trust

What does generative AI mean for health care? We asked experts

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

The cancer drug shortage isn’t new — and neither are the solutions

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

hotspot

Covid's long

Eli Lilly, Pfizer, and others want in on the online prescription market

Kim Kardashian sparks debate on benefits of full

Biotech venture capitalists face new demands from investors

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Elizabeth Holmes banned from government health programs

leisure time

entertainment

focus

leisure time